ACOR - Acorda Therapeutics Inc
IEX Last Trade
17.26
-0.340 -1.970%
Share volume: 11,619
Last Updated: Tue 08 Aug 2023 06:55:10 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$17.60
-0.34
-1.93%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-13 | 2022-08-09 | 2022-11-14 | 2023-03-15 | 2023-05-11 | 2023-08-09 | 2023-11-14 | |
| Total revenue | 22.534 M | 31.051 M | 33.511 M | 31.470 M | 22.258 M | 29.675 M | 27.715 M | |
| Cost of revenue | 5.967 M | 8.800 M | 11.005 M | 4.560 M | 3.234 M | 3.065 M | 3.387 M | |
| Gross profit | 16.567 M | 22.251 M | 22.506 M | 26.910 M | 19.024 M | 26.610 M | 24.328 M | |
| 34.31% | 1.15% | 19.57% | -29.31% | 39.88% | -8.58% | |||
| Operating expenses | 28.632 M | 31.592 M | 24.380 M | 27.456 M | 23.900 M | 23.375 M | 24.359 M | |
| Selling general and admin | 26.938 M | 30.067 M | 22.997 M | 26.254 M | 22.514 M | 21.825 M | 23.152 M | |
| Research and development | 1.694 M | 1.525 M | 1.383 M | 1.202 M | 1.386 M | 1.550 M | 1.207 M | |
| Total expenses | 42.290 M | 48.083 M | 43.076 M | 39.707 M | 34.825 M | 34.131 M | 35.437 M | |
| 13.70% | -10.41% | -7.82% | -12.30% | -1.99% | 3.83% | |||
| Operating income | -19.756 M | -17.032 M | -9.565 M | -8.237 M | -12.567 M | -4.456 M | -7.722 M | |
| Ebit | -19.756 M | -17.032 M | -9.565 M | 4.317 M | -12.567 M | -4.456 M | -7.722 M | |
| Pretax income | -24.264 M | -20.119 M | -12.438 M | 21.574 M | -18.862 M | -11.346 M | -9.943 M | |
| -17.08% | -38.18% | -273.45% | -187.43% | -39.85% | -12.37% | |||
| Income tax | 258.000 K | 26.563 M | 1.416 M | 2.432 M | -2.038 M | -1.965 M | -1.055 M | |
| Net income basic | -24.522 M | -46.682 M | -13.854 M | 19.142 M | -16.824 M | -9.381 M | -8.888 M | |
| -90.37% | 70.32% | 238.17% | -187.89% | 44.24% | 5.26% | |||
| Net income | -24.522 M | -46.682 M | -13.854 M | 19.142 M | -16.824 M | -9.381 M | -8.888 M | |
| -90.37% | 70.32% | 238.17% | -187.89% | 44.24% | 5.26% |